RIBOZYME - RNA AS AN ENZYME, BUT AS A THERAPEUTIC

Ribozyme Pharmaceuticals, Inc. is based on a distinctive technology wh ich uses antisense molecules that are also enzymes. An obvious use of these molecules is in the cleavage of mRNA for genes expressed in dise ase states portfolio of patented ribozyme sequences relevant to a wide range of or those encoded by infecting viruses. The Company has an im pressive disorders, although questions remain over the degree of homol ogy needed to target the enzyme and their stability and activity.